A Study to Assess the Ability of Stereotactic Radiotherapy to Restore the Efficacy of Immunotherapy in Patients With Metastatic Cancer.

NANot yet recruitingINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

January 31, 2025

Primary Completion Date

April 30, 2025

Study Completion Date

January 31, 2027

Conditions
Metastatic Cancer
Interventions
RADIATION

Stereotactic Radiotherapy

"Patients will perform stereotactic radiotherapy with 3 sessions (8 Gy) during 20 minutes each and with 72 hours in-between.~Patients enrolled in the study would not have received this stereotactic radiotherapy outside the study, that is why this procedure is additional (compared to Standard of care) and considered as burdensome (as this is radiation). Before performing the stereotactic radiotherapy, patients will do a radiotherapy CT scanner (no injected) in order to prepare precisely the radiotherapy (treatment plan)."

Trial Locations (1)

16800

Centre Clinical, Soyaux

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Elsan

OTHER

NCT06363773 - A Study to Assess the Ability of Stereotactic Radiotherapy to Restore the Efficacy of Immunotherapy in Patients With Metastatic Cancer. | Biotech Hunter | Biotech Hunter